Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70892-3 ◽

2007 ◽

Vol 5 (4) ◽

pp. 223

Author(s):

N. Tubiana-Mathieu ◽

P. Bougnoux ◽

D. Becquart ◽

A. Chan ◽

F. Majois ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Oral Vinorelbine ◽

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

BMC Cancer ◽

10.1186/1471-2407-6-76 ◽

2006 ◽

Vol 6 (1) ◽

Cited By ~ 8

Author(s):

Alessandro Passardi ◽

Ilaria Massa ◽

Wainer Zoli ◽

Lorenzo Gianni ◽

Carlo Milandri ◽

...

Keyword(s):

Breast Cancer ◽

Translational Research ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Research Experience ◽

First Line ◽

A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdg111 ◽

2003 ◽

Vol 14 (3) ◽

pp. 433-440 ◽

Cited By ~ 13

Author(s):

R. Paridaens ◽

F. Van Aelst ◽

V. Georgoulias ◽

H. Samonnig ◽

V. Cocquyt ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC). Final results of a Phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(02)80203-9 ◽

2002 ◽

Vol 38 (11) ◽

pp. S68 ◽

Cited By ~ 1

Author(s):

S Morales

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

5075 POSTER Non-pegylated Liposomal Doxorubicin (Myocet e) Plus Docetaxel (Taxotere e) (MYTAX), as First-line Chemotherapy (CHT), in Metastatic Breast Cancer (MBC): Results of a Phase II Study

European Journal of Cancer ◽

10.1016/s0959-8049(11)71517-9 ◽

2011 ◽

Vol 47 ◽

pp. S353

Author(s):

L. Imperatori ◽

P. Lippe ◽

C. Trapuzzano ◽

G. Laid ◽

C. Cappelletti ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

First Line ◽

Phase II study with dose finding of Oral Vinorelbine in combination with Capecitabine as first-line chemotherapy of Metastatic Breast Cancer (MBC): Preliminary results of the phase II part of the study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80428-3 ◽

2006 ◽

Vol 4 (2) ◽

pp. 167 ◽

Cited By ~ 1

Author(s):

F. Nolè ◽

Catania ◽

G. Sanna ◽

R. Mattioli ◽

D. Crivellari ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Dose Finding ◽

First Line ◽

Oral Vinorelbine ◽

Preliminary Results ◽

A Phase II Study of Sequential Docetaxel Followed by Doxorubicin/Cyclophosphamide as First-Line Chemotherapy For Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2003.n.034 ◽

2003 ◽

Vol 4 (4) ◽

pp. 286-291 ◽

Cited By ~ 5

Author(s):

Antonio Antón ◽

Javier Hornedo ◽

Ana Lluch ◽

Bartomeu Massuti ◽

Mónica Corral ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Sequential treatment of docetaxel plus doxorubicin/ cyclophosphamide (AC) as first-line chemotherapy for metastatic breast cancer (MBC). Final results and survival analysis of a phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(02)80204-0 ◽

2002 ◽

Vol 38 (11) ◽

pp. S68-S69

Author(s):

A Antón

Keyword(s):

Breast Cancer ◽

Survival Analysis ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Sequential Treatment ◽

First Line ◽

454 A phase II study of vinorebline (VRL) alterning oral and intravenous (IV) plus epirubicin (EPI) as first line chemotherapy of metastatic breast cancer (MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90486-1 ◽

2003 ◽

Vol 1 (5) ◽

pp. S138-S139

Author(s):

M. Verrill ◽

D. Serin ◽

A. Jones ◽

T. Delozier ◽

R. Coleman

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Phase II Study of Concurrent Administration of Doxorubicin and Docetaxel as First-Line Chemotherapy for Metastatic Breast Cancer

Oncology ◽

10.1159/000067771 ◽

2003 ◽

Vol 64 (2) ◽

pp. 124-130 ◽

Cited By ~ 11

Author(s):

Tomohiko Aihara ◽

Yuichi Takatsuka ◽

Kuniaki Itoh ◽

Yasutsuna Sasaki ◽

Noriyuki Katsumata ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Concurrent Administration ◽